Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Veeva Unveils AI Study Builder Agent Claiming One‑Day Clinical Trial Setup

26 September 2026 · By · Wire by Fusion42

Published

26 September 2026

Topic

opportunities

◆ Sectors

AI AgentsDigital Health

◆ Geography

United States

◆ Source

Read at saasrise.com →

◆ Verified

Fusion42 · 27 September 2026 · Fusion42 review

Veeva Systems announced its AI-driven Study Builder Agent that can configure a clinical trial study in as little as one day, automating key tasks such as EDC form setup and data quality checks. The product will be available to early adopters in December 2026 and integrates with Veeva’s existing clinical trial platforms without an extra license fee.

This Wire brief sits within Fusion42's coverage of AI Agents and Digital Health.

◆ ◆ The Wire takeaway

You can now drastically cut clinical trial setup time with AI that respects regulatory standards. This opens a path to win pharma clients by embedding AI into workflows that competitors still struggle to automate.

◆ Coverage

1 source · 26 Sep 2026

◆ Related on Wire

◆ Topics

AI AgentsDigital Healthai-automationclinical-trialshealthtechedccdisc